Corcept Therapeutics | Vertriebs- Und Verwaltungskosten



Selling And Administration Expenses Veränderung Datum
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Alaunos Therapeutics USD 1.01M 17K 2024-09
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Ardelyx USD 76.07M 11.1M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
J&J USD 6.45B 975M 2024-12
Knight Therapeutics CAD 25.48M 119K 2024-09
Merck USD 2.85B 148M 2024-12
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
TG Therapeutics USD 38.96M 3M 2024-12



Corcept Therapeutics Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.